The effects of global warming have long been a focus of scientists' attention, not only since the USA rejected the Kyoto Protocol, which was drafted to curb the emission of so-called greenhouse gases. The potential consequences of increasing the Earth's temperature by just a few degrees include a rise in ocean levels due to melting of the polar ice caps, parching of the land and changes of storm, flood and drought patterns. These scenarios are mainly debated among climatologists, but biologists are adding a further dimension with another potentially disastrous effect.
'In the past five years, there has been increasing discussion about global warming and its potential impact on diseases like malaria and dengue fever in the tropics and even in temperate zones', Uriel Kitron, Professor of Epidemiology at the University of Illinois in Urbana-Champaign, said. Indeed, many scientists point to global warming as a factor in the spread of malaria and other vector-borne infectious diseases. This camp believes that global warming is likely to disturb a delicate equilibrium and contribute to new epidemics of malaria, yellow and dengue fever and encephalitis.
Kitron has been studying the invasion of the tiger mosquito in Illinois, LaCrosse encephalitis in the Great Lakes region, and dengue and malaria in Rising temperatures could also extend the transmission season for the dengue haemorrhagic fever/dengue shock viruses and increase the rate of their development within the vector, thus producing more infectious bites per year, they add. Droughts could encourage the storage of drinking water, thus increasing the number of development sites of its vector, the A. aegypti mosquito, while high rainfall could expand mosquito populations by producing new breeding grounds.
The increase of infectious diseases due to global warming was also a topic at the Cleveland Vector Encounter in July, where 60 researchers from the US and Canada gathered at Case Western Reserve University. Barry Alto of the University of Florida in Gainesville discussed the dynamics of temperature on Aedes albopictus, the Asian tiger mosquito. His paper, published in July in the Journal of Medical Entomology, examined how constant temperatures of 22, 24 and 26°C affect the full life-cycle of caged mosquitoes. Alto found that populations at higher temperatures increased faster and had shorter development times. 'The study suggests that regional differences in temperature are likely to affect the ability of species-most notably that of the Asian tiger mosquito-to colonise new areas', Alto said.
He concluded that higher temperatures associated with climate change-when considered alone-'seem likely to expand the region of North America that is suitable for A. albopictus. Warmer winter temperatures should reduce winter mortality. Warmer summer temperatures should favour earlier, more rapid production of adults, and yield an increase in the rate of spread of A. albopictus to new sites. ' In another study, published in the August issue of Journal of Medical Entomology, Patz and co-author Steven Juliano examined rainfall and temperature effects on A. albopictus. Specifically, they found that greater temperatures and the absence of drying resulted in larger production of adult mosquitoes while greater temperatures with drying diminished populations. 'These results suggest that populations occurring in warmer regions are likely to produce more adults as long as containers [mosquito-breeding grounds] do not dry completely', Alto said. He concluded that 'predicted climate change in North America is likely to extend the northern distribution of A. albopictus and to limit further its establishment in arid regions'. These conclusions may also pertain to dengue, LaCrosse encephalitis and Venezuelan equine encephalitis, which have been spreading through the Americas, Alto said. Of course, such problems would not be limited to the Americas, but would also pertain to other areas with higher temperatures and sufficient rainfall, such as southern Europe or northern Australia.
But there are many factors to take into account. 'I believe that with global warming, patterns of disease could change, but how that will occur is unclear', Kitron cautioned. Global warming could create a mixture of conditions that is as yet unknown; for example, less moisture or rainfall and higher temperatures could undo the effects of warming, he added. He also pointed out that social causes are at least as important risk factors as rising temperatures. Paul Reiter of the Centers of Disease Control (CDC) in Atlanta, GA, supports Kitron, noting that the life-cycle and distribution of vectors and infectious diseases are far more complex than others acknowledge. Reiter cited numerous cases of historical malaria epidemics during record cold temperatures in specific regions, such as the first major epidemic of dengue in 1780s in Philadelphia where A. aegypti survived the winters in basements where water was stored, malaria epidemics in Russia and Finland in 1939-40, and in Poland through the 1950s. 'There is tremendous distribution of vector-borne diseases in temperate regions, and this has always been the case', he said. 'It is unfortunate that public perception is distorted by people who know little about the field'. This line of thinking is 'politically sexy' but reductionist, he said.
In April 2001, an interdisciplinary committee of the National Academy of Sciences' National Research Council (NRC) published a report arguing that there is 'little solid scientific evidence' to support warnings that climate change will promote an upsurge of dengue, malaria and yellow fever. The report noted that a number of the studies used to support the correlation of vector-borne diseases with global warming were short-term in focus, and covered relatively small areas of territory. Furthermore, models based on such studies do not consider other factors, such as sanitation, land use, public health practices, and other behaviour. One example the report gave is the incidence of dengue fever on either side of the USMexican border. In the 16 years after 1980, there were over 50 000 confirmed cases of dengue in the three Mexican states bordering the Rio Grande. During the same time period, there were fewer than 100 cases on the Texas side. Public health differences-not climate-account for this discrepancy; screens on windows, air-conditioning and fewer hours spent at home result in a lower incidence of mosquito bites in Texas.
Similarly, the CDC acknowledged that 'changes in regional climate patterns caused by long-term global warming Warming trends in the American southwest could endanger non-immune elderly persons who spend the winter there Public health differences-not climate-account for the large discrepancy of cases of dengue fever along the border between Texas and Mexico could affect the potential geographic range of many infectious diseases', but adds, 'if the climate of some regions becomes more suitable for transmission of disease agents, human behavioural adaptations and public health interventions could mitigate many adverse impacts'. However different the interpretations might be, at least all scientists involved agree that the interaction between climate, human behaviour and vectorborne disease is simply too complex for scientists to be able to make accurate predictions. 'The potential exists for scientists one day to be able to predict the impact of global climate change on disease, but that day is not here', Donald Burke, Professor of International Health and Epidemiology at Johns Hopkins School of Public Health in Baltimore, MD, and chair of the NRC panel, remarked. Nevertheless, whether the threat of vector-borne diseases spreading into new areas is realised or not, the fact that biologists are also seeing potentially detrimental effects from rising global temperatures is worrisome enough. It should render additional arguments to the supporters of the Kyoto Protocol, who see it as a necessary first step to curb global warming.
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The problem of emerging resistance is greatest in hospital environments where the high level of antibiotic use and the propensity for genetic exchange between bacterial populations provide a perfect breeding ground for multi-resistant superbugs. Worldwide deaths from methicillinand the emerging vancomycin-resistant Staphylococcus aureus (MRSA and VRSA, respectively) amount to 5000 each year. Previously benign organisms such as Enterococcus faecalis, Acinetobacter and Xanthomonas can now be fatal to hospitalised patients with compromised immunity. But also in the community, Streptococcus pneumoniae and Neisseria gonorrhoeae that were once easily treatable with penicillin, are now resistant to most common antibiotics. An analysis of non-hospital antibiotic sales in the 15 European Union member states (Table I) , published last June in The Lancet by Otto Cars and co-workers from the Department of Infectious Diseases at the University Hospital in Uppsala, Sweden, highlights the problem of over-prescribing. In 1997, France and Spain were the highest 'The potential exists for scientists one day to be able to predict the impact of global climate change on disease, but that day is not here' There is a prevailing attitude which borders on a sense of complacency that science will provide the answer
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